The University of Southampton
University of Southampton Institutional Repository

Heterogeneity of NMDA receptors labelled with [3H]3-((±)-2-carboxypiperazin-4-yl)propyl-1-phosphonic acid ([3H]CPP): receptor status in Alzheimer's disease brains

Heterogeneity of NMDA receptors labelled with [3H]3-((±)-2-carboxypiperazin-4-yl)propyl-1-phosphonic acid ([3H]CPP): receptor status in Alzheimer's disease brains
Heterogeneity of NMDA receptors labelled with [3H]3-((±)-2-carboxypiperazin-4-yl)propyl-1-phosphonic acid ([3H]CPP): receptor status in Alzheimer's disease brains

The binding of [3H]3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid ([3H]CPP) was studied in rat and human brain synaptic membranes. Specific binding was saturable, reversible and inhibited by a range of compounds active at N-methyl-D-aspartate (NMDA) receptors such as 2-amino-5-phosphonopentanoate (AP5), 2-amino-7-phosphonoheptanoate (AP7), NMDA and cis-2,4-methanoglutamate. Binding was heterogeneous as evidenced by non-linear Scatchard plots and Hill coefficients for binding inhibitors significantly different from unity. LIGAND analysis of the binding data indicated the likely presence of two distinct binding components for CPP, one of high (Kd values approx. = 70 nM) and the other of low (Kd values approx. 5 μM) affinity. Possible alterations in the binding of [3H]CPP to either site were investigated in medial frontal and medial temporal cortex from Alzheimer's disease brains and compared with control tissues, carefully matched for age and postmortem delay. While there were considerable inter-individual variations in binding, no significant differences were detected either between brain regions in either Alzheimer or control subjects, or between Alzheimer's disease and control brains. These data suggest the presence of at least two components of [3H]CPP binding in both rat and human brain tissue. The integrity of neither of these components is altered in Alzheimer's disease, consistent with a lack of gross alterations of NMDA receptors in this disorder.

Alzheimer's disease, Brain (rat), Cortex (human), NMDA receptors, [H]CPP([H]3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid)
0922-4106
195-197
Porter, Richard H.P.
d977ae5c-0112-4ea7-8a8e-951b03a94649
Cowburn, Richard F.
a5d9f8e5-7785-4726-9b11-9143c2c3f593
Alasuzoff, Irina
63b7136f-d926-4c9b-a299-d49c291a3306
Briggs, Roger S.J.
a6b65ef0-e90c-4c07-bf5b-b70130c128b3
Roberts, Peter J.
ab0ce3bd-e5a0-42a9-818c-ad502d7789f3
Porter, Richard H.P.
d977ae5c-0112-4ea7-8a8e-951b03a94649
Cowburn, Richard F.
a5d9f8e5-7785-4726-9b11-9143c2c3f593
Alasuzoff, Irina
63b7136f-d926-4c9b-a299-d49c291a3306
Briggs, Roger S.J.
a6b65ef0-e90c-4c07-bf5b-b70130c128b3
Roberts, Peter J.
ab0ce3bd-e5a0-42a9-818c-ad502d7789f3

Porter, Richard H.P., Cowburn, Richard F., Alasuzoff, Irina, Briggs, Roger S.J. and Roberts, Peter J. (1992) Heterogeneity of NMDA receptors labelled with [3H]3-((±)-2-carboxypiperazin-4-yl)propyl-1-phosphonic acid ([3H]CPP): receptor status in Alzheimer's disease brains. European Journal of Pharmacology: Molecular Pharmacology, 225 (3), 195-197. (doi:10.1016/0922-4106(92)90020-V).

Record type: Article

Abstract

The binding of [3H]3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid ([3H]CPP) was studied in rat and human brain synaptic membranes. Specific binding was saturable, reversible and inhibited by a range of compounds active at N-methyl-D-aspartate (NMDA) receptors such as 2-amino-5-phosphonopentanoate (AP5), 2-amino-7-phosphonoheptanoate (AP7), NMDA and cis-2,4-methanoglutamate. Binding was heterogeneous as evidenced by non-linear Scatchard plots and Hill coefficients for binding inhibitors significantly different from unity. LIGAND analysis of the binding data indicated the likely presence of two distinct binding components for CPP, one of high (Kd values approx. = 70 nM) and the other of low (Kd values approx. 5 μM) affinity. Possible alterations in the binding of [3H]CPP to either site were investigated in medial frontal and medial temporal cortex from Alzheimer's disease brains and compared with control tissues, carefully matched for age and postmortem delay. While there were considerable inter-individual variations in binding, no significant differences were detected either between brain regions in either Alzheimer or control subjects, or between Alzheimer's disease and control brains. These data suggest the presence of at least two components of [3H]CPP binding in both rat and human brain tissue. The integrity of neither of these components is altered in Alzheimer's disease, consistent with a lack of gross alterations of NMDA receptors in this disorder.

This record has no associated files available for download.

More information

Published date: 12 March 1992
Keywords: Alzheimer's disease, Brain (rat), Cortex (human), NMDA receptors, [H]CPP([H]3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid)

Identifiers

Local EPrints ID: 479049
URI: http://eprints.soton.ac.uk/id/eprint/479049
ISSN: 0922-4106
PURE UUID: a6380e0e-b3a0-46bb-ac14-90aa69102152

Catalogue record

Date deposited: 19 Jul 2023 16:37
Last modified: 17 Mar 2024 03:36

Export record

Altmetrics

Contributors

Author: Richard H.P. Porter
Author: Richard F. Cowburn
Author: Irina Alasuzoff
Author: Roger S.J. Briggs
Author: Peter J. Roberts

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×